Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model.

Khurana V, Lu Y, Steinhilb ML, Oldham S, Shulman JM, Feany MB.

Curr Biol. 2006 Feb 7;16(3):230-41.

2.

Oxidative stress mediates tau-induced neurodegeneration in Drosophila.

Dias-Santagata D, Fulga TA, Duttaroy A, Feany MB.

J Clin Invest. 2007 Jan;117(1):236-45. Epub 2006 Dec 14.

3.

Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.

Ferrer I, Barrachina M, Tolnay M, Rey MJ, Vidal N, Carmona M, Blanco R, Puig B.

Brain Pathol. 2003 Jan;13(1):62-78.

PMID:
12580546
4.

Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.

Padmanabhan J, Levy M, Dickson DW, Potter H.

Brain. 2006 Nov;129(Pt 11):3020-34. Epub 2006 Sep 20.

5.
6.

Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy.

Cente M, Filipcik P, Pevalova M, Novak M.

Eur J Neurosci. 2006 Aug;24(4):1085-90.

PMID:
16930434
9.

DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3.

McPhie DL, Coopersmith R, Hines-Peralta A, Chen Y, Ivins KJ, Manly SP, Kozlowski MR, Neve KA, Neve RL.

J Neurosci. 2003 Jul 30;23(17):6914-27.

10.

Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.

Fulga TA, Elson-Schwab I, Khurana V, Steinhilb ML, Spires TL, Hyman BT, Feany MB.

Nat Cell Biol. 2007 Feb;9(2):139-48. Epub 2006 Dec 24.

PMID:
17187063
11.

Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregation.

Schindowski K, Belarbi K, Bretteville A, Ando K, Buée L.

Genes Brain Behav. 2008 Feb;7 Suppl 1:92-100. doi: 10.1111/j.1601-183X.2007.00377.x.

12.

Connecting cell-cycle activation to neurodegeneration in Drosophila.

Khurana V, Feany MB.

Biochim Biophys Acta. 2007 Apr;1772(4):446-56. Epub 2006 Oct 18. Review.

13.

p53 prevents neurodegeneration by regulating synaptic genes.

Merlo P, Frost B, Peng S, Yang YJ, Park PJ, Feany M.

Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):18055-60. doi: 10.1073/pnas.1419083111. Epub 2014 Dec 1.

14.

Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.

Kraemer BC, Zhang B, Leverenz JB, Thomas JH, Trojanowski JQ, Schellenberg GD.

Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9980-5. Epub 2003 Jul 18.

16.

Challenges in neuronal apoptosis.

Jellinger KA.

Curr Alzheimer Res. 2006 Sep;3(4):377-91. Review.

PMID:
17017868
17.

A comparison of the neuronal dysfunction caused by Drosophila tau and human tau in a Drosophila model of tauopathies.

Ubhi KK, Shaibah H, Newman TA, Shepherd D, Mudher A.

Invert Neurosci. 2007 Sep;7(3):165-71. Epub 2007 Jul 18.

PMID:
17636367
18.

NMNAT suppresses tau-induced neurodegeneration by promoting clearance of hyperphosphorylated tau oligomers in a Drosophila model of tauopathy.

Ali YO, Ruan K, Zhai RG.

Hum Mol Genet. 2012 Jan 15;21(2):237-50. doi: 10.1093/hmg/ddr449. Epub 2011 Sep 30.

19.

Metabolic/signal transduction hypothesis of Alzheimer's disease and other tauopathies.

Iqbal K, Grundke-Iqbal I.

Acta Neuropathol. 2005 Jan;109(1):25-31. Epub 2005 Jan 11. Review.

PMID:
15645264
20.

The cell cycle as a therapeutic target for Alzheimer's disease.

Neve RL, McPhie DL.

Pharmacol Ther. 2006 Jul;111(1):99-113. Epub 2005 Nov 7. Review.

PMID:
16274748
Items per page

Supplemental Content

Write to the Help Desk